BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29701170)

  • 1. Diagnosing and treating dementia in German primary and specialized care between 2011 and 2015
.
    Michalowsky B; Kostev K; Iliffe S; Hoffmann W; Bohlken J
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):301-309. PubMed ID: 29701170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indicators of an increase in dementia diagnosis rate in primary care].
    Michalowsky B; Kostev K; Hoffmann W; Bohlken J
    Z Gerontol Geriatr; 2018 Jul; 51(5):517-522. PubMed ID: 29098382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sharp increase in newly diagnosed patients with dementia in German primary care practices 2013. Better diagnostic process or monetary incentives?].
    Bohlken J; Michalowsky B; Kostev K
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):467-473. PubMed ID: 28841745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.
    Jacob L; Bohlken J; Kostev K
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):9-15. PubMed ID: 27879194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic and Prescription Behavior of General Practitioners and Specialist Physicians in Patients with Dementia in 2005 and 2015 in Germany].
    Bohlken J; Kostev K
    Psychiatr Prax; 2018 Apr; 45(3):154-159. PubMed ID: 28499316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidementia drug treatment in people screened positive for dementia in primary care.
    Wucherer D; Eichler T; Kilimann I; Hertel J; Michalowsky B; Thyrian JR; Teipel S; Hoffmann W
    J Alzheimers Dis; 2015; 44(3):1015-21. PubMed ID: 25391382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study.
    Donegan K; Fox N; Black N; Livingston G; Banerjee S; Burns A
    Lancet Public Health; 2017 Mar; 2(3):e149-e156. PubMed ID: 29253388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use.
    Wübbeler M; Wucherer D; Hertel J; Michalowsky B; Heinrich S; Meyer S; Schaefer-Walkmann S; Hoffmann W; Thyrian JR
    BMC Health Serv Res; 2015 May; 15():205. PubMed ID: 25998147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the prescribing of atypical antipsychotics in elderly patients with dementia in Korea
.
    Seo N; Song I; Park H; Ha D; Shin JY
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):581-587. PubMed ID: 28372635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.
    Koller D; Hua T; Bynum JP
    J Am Geriatr Soc; 2016 Aug; 64(8):1540-8. PubMed ID: 27341454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.
    Bohlken J; Weber S; Rapp MA; Kostev K
    Int Psychogeriatr; 2015 Aug; 27(8):1335-42. PubMed ID: 25899936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence with antidepressant drugs in patients with dementia: a retrospective database analysis.
    Booker A; Bohlken J; Rapp MA; Kostev K
    Int J Clin Pharmacol Ther; 2016 May; 54(5):323-9. PubMed ID: 27008002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the Documented Dementia Diagnoses in German Primary Care with the Prevalence Estimate for 2021].
    Bohlken J; Riedel-Heller SG; Kostev K; Michalowsky B
    Psychiatr Prax; 2024 Jan; 51(1):45-48. PubMed ID: 37813361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unintended effects of a cost-containment policy: results of a natural experiment in Germany.
    Schöffski O; Graf von der Schulenburg JM
    Soc Sci Med; 1997 Nov; 45(10):1537-9. PubMed ID: 9351143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.
    Jeschke E; Ostermann T; Vollmar HC; Tabali M; Schad F; Matthes H
    BMC Neurol; 2011 Aug; 11():99. PubMed ID: 21824429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior.
    Borson S; Scanlan J; Hummel J; Gibbs K; Lessig M; Zuhr E
    J Gen Intern Med; 2007 Jun; 22(6):811-7. PubMed ID: 17447100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitals and GPs are offered incentives to reduce antibiotic prescribing.
    Wise J
    BMJ; 2016 Mar; 352():i1499. PubMed ID: 26977082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.